Affordable Access

Pemetrexed plus carboplatin or cisplatin as neoadjuvant treatment of operable malignant pleural mesothelioma (MPM).

Authors
Type
Published Article
Journal
Anticancer Research
1791-7530
Publisher
International Institute of Anticancer Research
Publication Date
Volume
32
Issue
12
Pages
5393–5399
Identifiers
PMID: 23225442
Source
Medline
License
Unknown

Abstract

AC and AP are active and feasible neoadjuvant regimens. Progression-free survival, response, disease control and resection rate were similar in the two treatment groups. The lower tolerability to AP treatment could impair the clinical condition of patients undergoing surgery.

Statistics

Seen <100 times